Sangamo Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGMO and other ETFs, options, and stocks.

About SGMO

Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases. 

CEO
Alexander D. Macrae
CEOAlexander D. Macrae
Employees
183
Employees183
Headquarters
Richmond, California
HeadquartersRichmond, California
Founded
1995
Founded1995
Employees
183
Employees183

SGMO Key Statistics

Market cap
122.35M
Market cap122.35M
Price-Earnings ratio
-0.82
Price-Earnings ratio-0.82
Dividend yield
Dividend yield
Average volume
4.51M
Average volume4.51M
High today
$0.3871
High today$0.3871
Low today
$0.3552
Low today$0.3552
Open price
$0.3791
Open price$0.3791
Volume
4.29M
Volume4.29M
52 Week high
$1.40
52 Week high$1.40
52 Week low
$0.3552
52 Week low$0.3552

Stock Snapshot

Sangamo Therapeutics(SGMO) stock is priced at $0.37, giving the company a market capitalization of 122.35M. It carries a P/E multiple of -0.82.

On 2026-01-28, Sangamo Therapeutics(SGMO) stock moved within a range of $0.36 to $0.39. With shares now at $0.37, the stock is trading +4.2% above its intraday low and -4.4% below the session's peak.

Trading activity shows a volume of 4.29M, compared to an average daily volume of 4.51M.

The stock's 52-week range extends from a low of $0.36 to a high of $1.40.

The stock's 52-week range extends from a low of $0.36 to a high of $1.40.

People also own

Based on the portfolios of people who own SGMO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.